Evidence map›Paper›PMID 15593464›Full record

ArticleWorld journal of surgery2004

Andrenocortical carcinomas: twelve-year prospective experience.

Libuse Tauchmanovà, Annamaria Colao, Luigi Antonio Marzano, Lucianna Sparano, Luigi Camera, Annalisa Rossi, Giovanna Palmieri, Ettore Marzano, Marco Salvatore, Guido Pettinato and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
  17. Primary adrenocortical sarcomatoid carcinoma: case report and review of literature.Virchows Archiv : an international journal of pathology · 2008
    Article
  18. Article
  19. Article
  20. Large idiopathic unilateral adrenal hematoma in a young woman.Journal of endocrinological investigation · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Libuse TauchmanovàDepartment of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy. tauchman@unina.it
Annamaria Colao
Luigi Antonio Marzano
Lucianna Sparano
Luigi Camera
Annalisa Rossi
Giovanna Palmieri
Ettore Marzano
Marco Salvatore
Guido Pettinato
Gaetano Lombardi
Riccardo Rossi
University of Naples Federico II · ITFederico II University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenocortical carcinoma (AC) is a rare tumor with poor prognosis. Twenty-two patients (14 F, 8 M; age 22 to 59 years; median, 43 years) with AC were evaluated prospectively in a single center: tumor stage was I-II in 12 cases and III-IV in 10. The overall survival in our cohort was 41.6 +/- 42 months; 16 subjects are still alive. Curative surgery was followed by longer survival than debulking or no surgery (p < 0.0001). The first relapse was highly predictive for further recurrences. Recurrent ACs were progressively more aggressive, and they occurred with variable but ever shorter intervals. At diagnosis, 14 patients (63.5%) presented with features of clear adrenocortical hyperactivity. Despite the absence of clinical signs of hormonal excess, all other patients presented some abnormalities of steroid secretion. The most common clinical finding was a recent diagnosis of moderate-to-severe hypertension (68%), poorly controlled by pharmacological treatment, often associated with multiple cardiovascular risk factors. High mitotic rate and undifferentiated polymorph cellular pattern were associated with worse prognosis. Response to treatments other than surgery (mitotane chemotherapy) was better in patients treated early after the first surgery. In conclusion, curative surgery was the most effective treatment. Monitoring arterial pressure, endocrine parameters, and metabolic parameters can be helpful for the early detection of AC recurrences.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaAdultFemaleHumansMaleMiddle AgedProspective StudiesTime FactorsTreatment Outcome

Identifiers

PMID15593464
OpenAlexW1998000101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.